Abstract
Background: S100A14 is involved in multiple pathological processes; however, its role in nasopharyngeal carcinoma (NPC) is poorly understood. Methods: S100A14 was silenced (knockdown) or upregulated (overexpression) in 6-10B NPC cells. Results: S100A14-knockdown cells showed significantly higher proliferation rates in CCK-8 assays, increased motility in scratch experiments, and enhanced invasion in transwell assays compared with controls. Conversely, S100A14 overexpression induced S and G2/M phase cell cycle arrest and significantly increased the proportion of apoptotic cells. Molecular analysis showed decreased expression of Bcl-2 and Bcl-xl, alongside increased levels of Bax, Bad, cleaved-PARP, and cleaved-caspase-3/9. Conclusions: Knockdown of S100A14 promotes the malignancy of 6-10B cells, while its upregulation triggers caspase-dependent apoptosis, indicating that S100A14 acts as a tumor suppressor gene in NPC.
Introduction
Nasopharyngeal carcinoma (NPC) is a highly invasive malignancy particularly prevalent in Southern China and Southeast Asia. While advancements in radiotherapy have improved local control, distant metastasis remains a significant clinical challenge, affecting up to 40% of patients and leading to poor overall survival. Identifying the molecular "brakes" that prevent tumor progression is essential for developing more effective targeted therapies.
The S100 protein family is known to regulate critical cellular processes, including survival and inflammation. However, the role of S100A14 appears to be context-dependent; it acts as an oncogene in breast cancer but as a tumor suppressor in colorectal cancer. This study aimed to clarify the role of S100A14 in the progression of NPC.
Clinical Significance and Expression Patterns
Bioinformatics analysis of The Cancer Genome Atlas (TCGA) Head and Neck Squamous Cell Carcinoma (HNSC) cohort revealed that S100A14 expression is significantly lower in tumor tissues compared to healthy controls. Furthermore, clinical data analysis using PROGgeneV2 demonstrated that patients with lower S100A14 expression levels experienced significantly shorter metastasis-free survival times, suggesting its potential as a prognostic biomarker.
In vitro experiments confirmed these clinical observations. S100A14 levels were markedly lower in the NPC cell line 6-10B compared to the immortalized normal nasopharyngeal epithelial cell line NP69.
Functional Impact on Proliferation and Invasion
To investigate the functional consequences of S100A14 expression, researchers engineered 6-10B cells to either silence the gene (sh-S100A14) or overexpress it (S100A14-OE).
The Effect of S100A14 Knockdown
Silencing S100A14 led to a dramatic increase in malignancy. CCK-8 assays showed that optical density (OD) values—a proxy for cell proliferation—nearly doubled over a three-day period compared to control cells. Additionally, scratch and transwell assays revealed that knockdown cells migrated faster and invaded tissue more aggressively, narrowing the wound gap significantly more than the control group.
The Effect of S100A14 Overexpression
Restoring S100A14 expression had the opposite effect, effectively halting tumor progression. Overexpression significantly reduced the proliferation rate and inhibited the cells' ability to migrate and invade, reinforcing the protein's role as a vital suppressor of NPC malignancy.
Molecular Mechanisms: Apoptosis and Cell Cycle Arrest
The study identified that S100A14 suppresses tumor growth through a "double whammy" of cell cycle arrest and programmed cell death (apoptosis). Flow cytometry indicated that overexpressing S100A14 increased the rate of apoptosis from a baseline of ~2.7% to over 13%. This was accompanied by a significant increase in the proportion of cells arrested in the S and G2/M phases, preventing them from completing the division process.
Western blot analysis revealed that this suppression is mediated through the mitochondrial pathway. S100A14 shifts the balance of the Bcl-2 protein family, decreasing pro-survival proteins (Bcl-2, Bcl-xl) and increasing pro-death proteins (Bax, Bad). This shift triggers the activation of "executioner" enzymes, as evidenced by increased levels of cleaved-PARP and cleaved-caspase-3/9, the definitive molecular signatures of apoptosis.
Conclusion
These findings establish S100A14 as a critical tumor suppressor in nasopharyngeal carcinoma. By regulating the Bcl-2 family and inducing caspase-dependent apoptosis, S100A14 serves as a natural brake on tumor growth and metastasis. While these in vitro results are compelling, future in vivo studies using animal models will be necessary to fully evaluate the therapeutic potential of targeting S100A14 pathways in NPC patients.
Summary updated